{"id":"W3214174124","doi":"10.1182/blood-2021-146147","title":"Evaluation of the Safety of Emicizumab Prophylaxis in Persons with Hemophilia A: An Updated Summary of Thrombotic Events and Thrombotic Microangiopathies","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Thrombotic microangiopathy; Medicine; Microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura; Clinical trial; Atypical hemolytic uremic syndrome; MedDRA; Schistocyte; Internal medicine; Pediatrics; Adverse effect; Immunology; Pharmacovigilance; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008657955,0.0006721927,0.001353618,0.004785828,0.0002686918,0.001469141,0.0006066707,0.0005929925,0.001369828],"category_scores_gemma":[0.01477762,0.0002808277,0.001786508,0.00410662,0.000195182,0.000993069,0.0005303568,0.0008762826,0.0003986675],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008653879,"about_ca_system_score_gemma":0.001051725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001268309,"about_ca_topic_score_gemma":0.001725123,"domain_scores_codex":[0.9911655,0.002183423,0.003083589,0.0006048243,0.002798586,0.0001641369],"domain_scores_gemma":[0.9653728,0.008138363,0.01660545,0.001016259,0.008233067,0.0006340301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.005057945,0.0003326934,0.2504799,0.01020422,0.007127987,0.0003831439,0.0002727623,0.001461846,0.00267068,0.0004365284,0.03421393,0.6873583],"study_design_scores_gemma":[0.0009832289,0.00401754,0.8519442,0.007867069,0.01461926,0.004515431,0.000187571,0.002022966,0.0054029,0.0006764213,0.1076287,0.0001347815],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4169678,0.4849806,0.007536978,0.008544479,0.0007218168,0.00123952,0.04926914,0.0006759238,0.0300637],"genre_scores_gemma":[0.7826946,0.1452301,0.0126117,0.004068815,0.001724675,0.0009843988,0.04966014,0.00009304429,0.002932569],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008657955,"threshold_uncertainty_score":0.04578817,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02715124707715822,"score_gpt":0.2914351925890173,"score_spread":0.2642839455118591,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}